When subcutaneously administered to rats with 6-OHDA-induced PD, the cytokine mixture inhibited DAergic neuronal loss, increased neuronal Bcl-xL expression, and suppressed microglial IL-1β expression in the SNc. Here, IL1B is linked to Parkinson disease.